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A model of guided cell self-organization for rapid and 
spontaneous formation of functional vessels
L. Andrique1,2*†, G. Recher3,4†, K. Alessandri4, N. Pujol1,2, M. Feyeux4, P. Bon3,4, L. Cognet3,4, 
P. Nassoy3,4*‡, A. Bikfalvi1,2*‡
Most achievements to engineer blood vessels are based on multiple-step manipulations such as manual sheet 
rolling or sequential cell seeding followed by scaffold degradation. Here, we propose a one-step strategy using a 
microfluidic coextrusion device to produce mature functional blood vessels. A hollow alginate hydrogel tube is 
internally coated with extracellular matrix to direct the self-assembly of a mixture of endothelial cells (ECs) and 
smooth muscle cells (SMCs). The resulting vascular structure has the correct configuration of lumen, an inner lining 
of ECs, and outer sheath of SMCs. These “vesseloids” reach homeostasis within a day and exhibit the following 
properties expected for functional vessels (i) quiescence, (ii) perfusability, and (iii) contractility in response to 
vasoconstrictor agents. Together, these findings provide an original and simple strategy to generate functional 
artificial vessels and pave the way for further developments in vascular graft and tissue engineering and for deciphering 
the angiogenesis process.
INTRODUCTION
Three-dimensional (3D) cell cultures are emerging as a necessary 
approach to faithfully capture the behavior of cells in vivo and to 
improve our understanding of the fundamental cellular mechanisms 
under conditions that recapitulate the 3D architecture of an organ (1). 
These efforts are in line with those stemming from tissue engineering 
aiming at manufacturing artificial tissues and organs for regenerative 
medicine (2) and animal-free drug testing (3). The advancement of 
microfluidics and 3D printing technology applied to biological material 
has largely contributed to the recent development of organs-on-chips 
(4, 5) and bioprinted tissues and organs (6). The goal of organs-on-chips 
is not per se to recreate an organ but to model some basic physiological 
or pathological functions by designing a minimal system that in-
cludes fine control of the environment (perfusion, stretching, and 
drug circulation) (4). By contrast, bioprinting allows recapitulation 
of the organ or tissue shape, internal architecture, and function by 
combining a proper design of the 3D-printed templates (in terms of 
biocompatibility, degradability, and mechanical properties) with a 
sequential positioning strategy of cellular and environmental com-
ponents (7). Among the variety of recent achievements, two remarkable 
“tours de force” may be highlighted, namely, the reconstruction and 
implantation of a human external ear (8) and the fabrication of centimeter- 
thick vascularized tissues (9). These seemingly complex structures 
are built with no more than three cell types and two types of matrices. 
The underlying assumption in bioprinting is that positioned cells 
do not particularly reorganize throughout a developmental process 
(10). For this reason, it is crucial to reduce this likelihood by limiting 
the number of integrated cell types. As a corollary, the physiological 
relevance may also be altered. For instance, in an attempt to produce 
thick tissues that need to be vascularized to avoid necrosis due to 
restricted nutrients diffusion, the vast majority of current approaches 
consist in using only endothelial cells (ECs) and thus forming, 
strictly speaking, endothelial tubes (9). These tubular endothelial 
structures only partially mimic blood vessels, both in terms of cellu-
lar composition and functional properties: They ensure perfusability 
but fail to recapitulate the elasticity and contractility of blood vessels 
that are required for accommodating the pulsatile blood flow. An 
alternative to the all-in-one bioprinting strategy leading to minimal 
systems is to pursue a bottom-up approach in which multicellular 
modules are separately generated and subsequently assembled or 
printed into a more complex tissue (11).
A key step is to produce artificial well-organized vessels around 
which desired nonvascularized tissues can be grown or which can 
be used for vessel grafting. More specifically, in vitro blood vessels 
can be regarded as tubular tissues that exhibit (i) an organized his-
tological two-layered structure comprising a layer of smooth muscle 
cells (SMCs) enveloping a layer of ECs around a lumen and func-
tional properties such as (ii) contractility upon relevant stimuli and 
(iii) perfusability.
Previous works aiming at engineering blood vessels as two- 
layered tubular structures are based on elegant multiple-step ma-
nipulation including cell embedding in matrices, sheet rolling, or 
scaffold degradation (2, 12). Here, we propose a one-step procedure 
to produce mature functional blood vessels. Our scheme relies on 
directed self-assembly of SMCs and ECs within a tubular immune- 
protective alginate scaffold coated with an extracellular matrix 
(ECM). ECs and SMCs have indeed been previously shown to 
self-organize when mixed together (11). However, the resulting cel-
lular organization is a multicellular spheroid with SMCs being 
enveloped by ECs and with no lumen. This inverse configuration is 
consistent with the differential adhesion hypothesis (DAH) ex-
plaining that spheroids of highly contractile cells (such as SMCs), 
which exhibit a higher surface tension than spheroids of less con-
tractile cells (such as ECs), are preferably screened from contact 
with culture medium to reduce the surface energy of the binary cel-
lular mixture (13). To bias the outcome predicted by the DAH and 
guide cell self-assembly toward a correct vessel configuration, we have 
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designed a strategy that allows us to make dominant the interfacial 
energy of the boundary between the ECM and a tissue composed of 
only one type of cells in the self-organization process, as proposed 
by Gartner and co-workers (14). More concretely, using a 3D-printed 
microfluidic coextrusion device, we produced long permeable hy-
drogel tubes in which ECs and SMCs were coencapsulated in the 
presence of an ECM. Microvessels, which we named “vesseloids,” of 
about 300 m in diameter were formed and exhibit the main prop-
erties of mature blood vessels. In particular, (i) the typical histology 
of vessels is obtained within 1 day, (ii) the overall cell population 
becomes quiescent after a few days, and the vesseloids are (iii) per-
fusable and (iv) contractile in response to vasoconstrictor agents.
These artificial blood vessels are valuable models to study vessel 
formation and cell polarization in 3D at both morphological and 
molecular levels and to elucidate the implicated signaling pathways 
under standard conditions or in response to mechanical forces or drugs. 
Moreover, our vesseloids that are neither embedded in bulk ECM 
nor plated within the cast of a solid chip (glass, plastic, or silicone- 
based) can be readily handled, which opens numerous practical 
applications in vascularized tissue engineering, vascular grafts, and, 
ultimately, regenerative medicine.
RESULTS
SMC and EC-laden tubes internally coated with ECM are 
formed in a single-step procedure
The method to fabricate core-shell alginate fibers using a coextru-
sion microfluidic device was inspired from previous works of the 
Takeuchi group (15). It also extends to tubular fibers—our previous 
work on cell encapsulation—that consisted in coating the internal 
wall of spherical alginate microcapsules with ECM (16). Briefly, the 
process is based on the use of a 3D-printed chip that allowed gener-
ating triple-coaxial laminar flows (Fig. 1A). The viscous alginate 
solution (AL) is injected into the outer channel, the core cell sus-
pension (CCS) in ECM-containing solution is flowed into the inner 
channel, and an intermediate d-sorbitol solution (IS) solution is 
dispensed into the intermediary channel to avoid internal alginate cross- 
linking due to cellular calcium release. The custom-designed chip 
(Fig. 1A, fig. S1, and data file S1) is immersed into the calcium bath 
to avoid surface tension effects that favor jet fragmentation into droplets 
due to the Rayleigh-Plateau instability. We chose human umbilical vein 
ECs (HUVECs) and vascular SMCs (vSMCs) as models for ECs and 
SMCs, respectively, and selected Matrigel as an ECM substitute. In 
the first series of experiments reported here, the cell fraction con-
tained in the CCS was set to about 33% of the core suspension volume. 
Before encapsulation, cells were dispersed in liquid Matrigel at 
4°C. The composition of the cell mixture was varied and finally set 
in the following proportions of 2:1 EC/SMC, which we found optimal. 
In particular, the formation of a homogeneous EC monolayer was 
impaired with lower EC proportions (e.g., EC/SMC = 1:1). These 
conditions allowed us (i) to generate a uniform and continuous 
micrometer-thick Matrigel coating of the tubular capsule internal 
wall (fig. S2) upon cross-linking of the alginate tube in a hot (T = 37°C) 
calcium bath and (ii) to rapidly achieve the complete cellular coverage 
of the internal tube surface. Upon coinjection and exit from the 
nozzle, rapid gelation of the alginate sheath ensured entrapment of 
the binary cell mixture (Fig. 1B, day 0). We observed random distri-
bution of cells and granular rendering by phase contrast microscopy 
at day 0. These morphological features underwent a marked change 
characterized by the emergence of a layered structure before day 1 
(Fig. 1B, day 1). By transducing HUVECs (nuclear eBFP2) and 
vSMCs (nuclear Tomato), we aimed at monitoring the dynamics of 
vesseloid formation. By starting live imaging 2 hours after encapsu-
lation, we observed that, although lumen was already formed, both 
HUVECs and vSMCs remained very dynamic for 22 hours (movie S1), 
suggesting profound and rapid reorganizations toward a homeo-
static configuration. The external diameter of the tube is set by the 
size of the nozzle exit. In this work, we produced meter-long tubes 
starting from 14 million ECs and 7 million SMCs (2:1 ratio) and 
using devices with nozzle diameters of 300, 350, and 450 m. The 
corresponding external alginate tube diameters were 265 ± 11 m, 
360 ± 11 m, and 448 ± 12 m, indicating slight alginate shrinkage 
upon gelation (fig. S3) (17). The inner tube diameter, which is related 
to the size of the vesseloid lumen, was then derived from the algi-
nate wall thickness (Fig. 1, C and D). Because of volume conserva-
tion in the composite jet, we theoretically expect the ratio between 
the AL flow rate and the IS + CCS flow rate to be the sole tuning 
parameter. Nonetheless, in practice, not only did the total flow rate 
also affect the morphology and uniformity (e.g., the absence of bulges) 
of the tube, but also, for a given total flow rate, we observed the shell 
thickness to slightly vary upon relative tuning of the three coflow 
rates (Fig. 1C). We performed all the experiments reported here by 
empirically optimizing the flow conditions. For instance, using a 
device with a nozzle of 450 m in diameter, we found that flow rates 
of 2 ml hour−1 (for AS) and 1 ml hour−1 (for IS and CCS) were ap-
propriate to produce uniform tubes over macroscopic lengths. Their 
outer tube diameter was Dout = 448 ± 12 m, and the inner tube di-
ameter was Din = 321 ± 21 m (Fig. 1E).
Rapid and spontaneous cellular organization leads to 
vesseloids structurally resembling mature blood vessels
To quantitatively characterize cell self-organization inside the ves-
seloids, we performed in toto immunostaining and fluorescence 
confocal microscopy. We used cell type–specific antibodies including 
endothelial anti-CD31 and -smooth muscle actin (SMA; Fig. 2A). 
As seen in the optical and transverse sections, a lumen was formed 
at day 1 (Fig. 2, A and B). Moreover, as depicted by immunostain-
ing, cells were sorted out within 1 day into a two-layered architec-
ture comprising an internal layer of HUVECs mostly lining the lumen 
and an external layer mainly composed of vSMCs facing the unla-
beled alginate shell (Fig. 2A). Some internal remnants of cells debris 
were sometimes found, suggesting incomplete removal of cells that 
have not integrated the self-assembled structure. This observation 
was reinforced by a quantitative image analysis (Fig. 2C). We mea-
sured the fluorescence intensity profiles averaged over a strip of 10 
pixels in width for both HUVEC and vSMC staining. Since vesseloid 
sections are not perfectly circular and because of variability from 
one tube to another, the profiles were first registered by taking the 
interface between the two peaks (Fig. 2C, n = 4 tubes) as a reference. 
This allowed us to derive the image of an “average tube.” We found 
two well-separated intensity profiles, confirming the correct histo-
logical position of the two cell populations. Last, additional immu-
nostaining of laminin, which is a native component of Matrigel, 
together with CD31 and SMA shows that Matrigel is visible at day 1 
and that vSMCs are intimately anchored into the ECM-like layer, as 
evidenced by the orange/yellow coloration of vSMCs, suggesting 
a strong affinity of vSMCs for laminin (Fig. 2D). Note that vSMC 
coverage is mono- or submonolayered. This configuration is a direct 
 o
n
 August 12, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Andrique et al., Sci. Adv. 2019; 5 : eaau6562     12 June 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
3 of 12
consequence of the reduced number of encapsulated vSMCs as 
compared to ECs and, most likely, of the use of Matrigel that favors 
the nonproliferative contractile phenotype of vSMCs (18).
Moreover, we investigated whether vesseloids have already 
formed an elastic lamina after culture for 1 day. Immunostaining 
using anti-elastin antibodies was negative, as expected for the early 
stages of vessel formation. However, we detected fibrillin when 
tissues were probed with anti–fibrillin-1 antibody (fig. S4A), sug-
gesting the onset of production of elastic lamina components. As 
another important evidence that vesseloids organize into mature 
blood vessels within 1 day, we observed that vascular endothelial 
(VE)- cadherin was strongly expressed and colocalized with CD31 
in HUVECs (fig. S4B), indicating the formation of adhesive contacts 
between neighboring cells within the EC monolayer.
Last, to pursue a thorough critical test of the significance of the 
vesseloid model, we aimed at determining whether a variety of other 
molecular features of native vessels was recapitulated here. These 
include the expression of (i) basal and luminal markers [e.g., integrin 
1 and podocalyxin (PODXL)], (ii) arterial and venous markers 
neuropilin-1,2 (NRP1/NRP2), and (iii) endothelial activation markers 
[vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule–1 (ICAM-1)] in regular culture conditions and in response to 
inflammatory stimuli. We first analyzed the expression of integrin beta-1 
(ITG1 basal marker) and PODXL (luminal marker) in 3D vesseloids 
compared to 2D cultures by reverse transcription quantitative poly-
merase chain reaction (RT-qPCR; fig. S5A). Expression of both 
markers was significantly enhanced by 1.5- and 2.5-fold, respectively, 
as compared to 2D control. Similarly, the expression of ICAM-1 and 
vascular cell adhesion molecule–1 (VCAM-1), two typical markers 
of an activated endothelium, was markedly increased in ECs from 
vesseloids compared to ECs cocultured 2D with SMCs, after CD31+ 
cell magnetic bead cell sorting (fig. S5B): 401-fold (ICAM-1) and 
3.72-fold (VCAM-1). Upon inflammatory cytokine stimulation with 
interleukin-1 or tumor necrosis factor– (fig. S5C), ICAM-1 and 
VCAM-1 expressions are also increased in a dose-dependent manner. 
Together, these control experiments strongly suggest the rapid for-
mation of an activable endothelium in vesseloids. In addition, we 
investigated whether vesseloids express arterial and/or venous markers 
(NRP1 and/or NRP2). From RT-qPCR analysis, we found that both 
markers were expressed at levels similar to 2D cultures, but with a 
prevalence of NRP1 (two fold), suggesting that HUVECs mainly 
maintain an arterial- like phenotype in vesseloids (fig. S5D). On the 
basis of the well-known plasticity of ECs in culture even for a short 
time (19), coculture with coronary artery SMCs has very likely promoted 
this arterial phenotype.
Longer-term evolution reveals vascular homeostasis
As shown above, vesseloids readily acquired the histological struc-
ture of mature blood vessels. However, whether this supracellular 
organization was in a homeostatic state similar to the one of mature 
Fig. 1. 3D vascular fabrication process. (A) Drawing of the microfluidic platform and picture of the coextrusion device. The three solutions are injected simultaneously 
by a computer-controlled pump, inside a 3D-printed device soaking in a 100 mM calcium bath; 2.5% AL, IS, and CCS (HUVEC/SMC/ECM). Scale bar, 1 cm. (B) Cell-laden 
tube after production (day 0) or after 1 day of culture (day 1). Scale bar, 200 m. (C) Measurements of the alginate wall thickness of alginate tubes produced with a 450-m 
nozzle exit coextrusion device for the following injection flow rates (n = 8): 2 ml hour−1 (AL), 1 ml hour−1 (IS), and 1 ml hour−1 (CCS); 2 ml hour−1 (AL), 1.5 ml hour−1 (IS), and 
0.5 ml hour−1 (CCS); or 2 ml hour−1 (AL), 0.5 ml hour−1 (IS), and 1.5 ml hour−1 (CCS). (D and E) Tube formation reproducibility: Measurements of external and internal diameters 
along the same tube, separated by at least 1 mm (n = 16). Photo Credit: Laetitia Andrique (INSERM U1029), Gaelle Recher (CNRS UMR 5298).
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Fig. 2. Self-organization into artificial mature blood vessels. (A and B) Confocal imaging of vesseloid immunostainings at day 1. Nuclei are gray (DAPI), CD31 is blue (endothelial marker), 
and SMA or tubulin labeling is orange. Images correspond to a maximal intensity projection along the z axis, except for the half panels indicated as “optical section,” which depict 
a representative image at the equatorial plane. Scale bars, 50 m. (C) Fluorescence intensity profiles of SMA and CD31. The four different measurements were aligned together 
based on the intersection between both intensity distributions, and this value was taken as the reference in the plot. Negative values indicate distance toward the alginate wall, and 
positive values indicate distance in the direction of the lumen. (D) Anchoring of SMCs in ECM. Immunostaining of laminin, CD31, and SMA was performed. Images correspond to a 
projection of the z axis of each signal. Nuclei are in gray (DAPI), laminin in green, CD31 endothelial marker in blue, and SMA in orange. Zoom of an equatorial section of the vesseloid. 
Scale bars, 100 m. (E) KI67 nuclear signal and histogram representation of proliferation at days 1 and 5. (F) Activated caspase-3 signal and histogram representation of 
apoptosis at days 1 and 5. Scale bars, 50 m. AU, arbitrary units; ns, not significant. Photo Credit: Laetitia Andrique (INSERM U1029), Gaelle Recher (CNRS UMR 5298).
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blood vessels in vivo had to be assessed. Since the default status of 
blood vessels under non-angiogenic, anti-inflammatory, and anti-
thrombotic conditions is quiescence (20), we sought to evaluate the 
expression of the proliferative marker KI67 independently of the 
cell type (Fig. 2E). One day after tube formation, both vSMCs and 
HUVECs were highly proliferative [80%, as assessed by 4′,6-diamidino- 
2-phenylindole (DAPI) counterstaining]. At day 5, KI67 nuclear 
staining became undetectable, indicating that all cells were nonpro-
liferative. As a control, we verified that this marked decrease in the 
fraction of proliferative cells was not concomitant with an increase 
in the number of apoptotic cells, which would indicate a collapsing 
vascular structure. Activated caspase-3 staining confirmed that cells 
were not undergoing apoptosis from day 1 to 5 (Fig. 2F) since only 
background level consistent with nonspecific noise was detected (21). 
Both proliferation and apoptosis marker detection indicated that 
HUVECs and vSMCs were in a quiescent state. The time required 
to reach homeostasis was mainly limited to the time necessary to 
obtain a complete and uniform coverage of the tube wall, and pro-
liferation may help to fill up empty space in the cellular tube to 
reach a confluent cellular lining. An alternative way to reach more 
rapidly uniform coverage is to increase the total cell number in the 
tube and, thus, the total cell volume fraction in the CCS. For this 
purpose, we loaded the tubes with a cell concentration of 38% (in 
the same proportion as before; EC/SMC = 2:1) and found that not 
only the vesseloids were formed within 1 day but also HUVECs and 
vSMCs were quiescent at day 1, as evidenced by the absence of pro-
liferation and apoptosis (fig. S6). This cell density is the practical 
limit above which tubes from the nozzle were irregular and became 
ill shaped. Together, our findings show that binary mixtures of ECs 
and SMCs were very efficiently guided toward a quiescent state in 
ECM-coated hollow tubes and that this process is sped up as the 
initial cell population is increased, leading to rapid contact inhibi-
tion and quiescence while not altering self-assembly (22). Vesseloids 
were then stable under these culture conditions for 1 to 2 weeks. 
After about 10 days, we observed cell delamination from the alginate 
shell and progressive collapse of the structure. Note that such an in 
vitro vesseloid stability is equivalent to the one reported in previous 
achievements of engineered vessels (23). Nonetheless, to demonstrate 
that stability could be further improved, we explored various culture 
conditions. In particular, vesseloids exhibited a prolonged stability 
under hypoxia (37°C, 5% CO2, 0.1% O2) compared to normoxia 
(fig. S7). This appreciable improvement needs to be explored in detail 
in future works and could be of primary importance for in vivo setting 
after grafting.
Tight junctions between ECs ensure vesseloid perfusability
To test whether vesseloids exhibit functional characteristics of blood 
vessels, we explored their perfusion and permeability properties. 
We developed a homemade perfusion device (Fig. 3, A and B) in 
which manually pulled glass pipettes inserted into the tubes and 
connected to a syringe pump were placed under a stereomicroscope. We 
injected solutions of fluorescent [fluorescein isothiocyanate (FITC)–
coupled] dextran polymer of different molecular weights at a con-
stant flow of 1 ml min−1 (Fig. 3, C and D, and movie S2). We imaged 
the fluorescent tubes (with or without cells) at the onset of dextran 
injection (t = 0) and after maintained perfusion for 10 min. We 
measured the cross-sectional intensity profile (Fig. 3E) to evaluate 
the penetration depth of the FITC-dextran probe within the algi-
nate wall or within the composite material made of the alginate wall 
and cell layers. Since the alginate hollow fiber serves as a scaffold for 
vesseloid formation, we first needed to find a probe that diffuses 
freely through the alginate gels in the absence of cells to further 
evaluate whether the bound two-layered cellular structure reduced 
the permeability. We selected 500- and 20-kDa dextrans, character-
ized by hydrodynamic radii rH of 3 and 15 nm, respectively (24). 
Although the fluorescence intensity profile measured with the 500-kDa 
dextran hardly broadened within 10 min (Fig. 3, C to E, row 1), the 
20-kDa dextran rapidly invaded the alginate wall (Fig. 3, C to E, row 
2). This behavior is consistent with previous reports of a mesh size 
for alginate gels in the range of 5 to 20 nm (25) and with theoretical 
obstruction models for molecular diffusion in heterogeneous gels 
such as alginate (26). From the measurement for the 20-kDa dex-
tran, we estimated a minimal value for its effective diffusion coef-
ficient, D ~ L2/t = 60 m2 s−1 (where L is the characteristic diffusion 
length; here, the thickness of the alginate wall), while the calculated 
value from Stokes-Einstein relation is D = kBT/(6rH) = 70 m2 s−1, with 
 as the viscosity of water (10−3 Pa s) and kBT as the thermal energy. 
These calculations predict that the diffusion of dextran through the 
alginate is equivalent to free diffusion in water and depicts accu-
rately what we observe. We then performed similar experiments 
with 20-kDa dextran injected into vesseloids that exhibit the 
above-described quiescent vessel-like structure, loaded with HUVECs 
only (Fig. 3, C to E, row 3) or with HUVECs and vSMCs (Fig. 3, C 
to E, row 4). As shown in Fig. 3D (row 4) and quantified in Fig. 3E, the 
probe penetration was hardly detectable (about 20% of the vessel + 
alginate thickness), indicating that HUVEC + vSMC layers signifi-
cantly decrease the permeability cutoff of the tube. This is in agreement 
with recent intravital two-photon excitation fluorescence microscopy 
experiments showing that skin blood vessels restrict the passage of 
dextran larger than 20 kDa for at least the first 10 min following 
injection (27). Last, we evaluated vascular tubes only composed 
of HUVECs (Fig. 3, C to E, row 3) to determine whether vSMCs also 
contribute to the reduced permeability. Again, we observed 20-kDa 
dextran to hardly leak through the EC-based vesseloid (about 10% 
of the vessel + alginate thickness), suggesting that EC organization 
was sufficient to create a barrier that mimics the permeability prop-
erties of blood vessels. Since tight junctions are known to be instru-
mental in controlling the vascular permeability, we performed 
transmission electron microscopy (TEM) on vesseloids (Fig. 3, F to I). 
The presence of EC characteristics such as mature Weibel-Palade 
bodies (Fig. 3F) and the expression of abundant lamellar bodies 
(Fig. 3, G and H) suggests a functional self-organization of an endo-
thelium (28). TEM micrographs also show an EC monolayer 
(Fig. 3I) (29) with tight junction between the cells (Fig. 3, G to I). 
A whole cross section of a vesseloid seen using TEM (fig. S8) also 
shows that SMC coverage of the endothelium is not complete. 
However, as described above, this does not jeopardize vesseloid 
perfusability, and as it will be seen below, these conditions are sufficient 
to allow vesseloid contractility in a range that is compatible with 
native blood vessel contractility. These findings indicate that the 
vesseloid wall recapitulates a major feature of a functional blood 
vessel wall and that a leak-free barrier is mainly provided by the sole 
endothelium.
Vesseloids exhibit vasoactivity
In blood vessels, one of the main functions of SMCs is contractility. 
To assess the vasoactivity of vesseloids, we primarily used endothelin-1 
(ET-1). ET-1 is a peptide originally isolated from the vascular endothelium 
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Fig. 3. Perfusable and liquid tight vesseloids. (A) Schematic drawing of the experimental design. The vesseloid is connected to a glass pipette for the perfusion of either 
dextran solution or culture medium for washing. (B) Photography of the perfusion device. (C) Schematic drawing of the experimental conditions. The left column depicts 
a longitudinal section alongside the glass pipet and the alginate tubes/vesseloids. The right column depicts the corresponding transverse sections. (D) Bright-field images 
of the tubes/vesseloids before perfusion (left column). Fluorescent images at t0 and 10 min after FITC-dextran perfusion (second and third columns). (C to E) Row 1: Alginate 
tube, perfusion of 500-kDa FITC-dextran. Row 2: Alginate tube, perfusion of 20-kDa FITC-dextran. Row 3: Vesseloid with HUVECs only, perfusion of 20-kDa FITC-dextran. 
Row 4: Vesseloid with HUVECs and vSMCs, perfusion of 20-kDa FITC-dextran. Scale bars, 200 m. (E) Normalized fluorescence profiles both at the onset of FITC-dextran 
injection to mark the lumen size (0 min) and after 10 min, superimposed with the bright-field section. Corresponding fluorescence full width at half maximum (FWHM). 
(F to I) Vesseloids imaged by TEM at high magnification (×25,000 and ×50,000) after 1 day of culture. Corresponding drawing with identification of Weibel-Palade bodies 
(WPBs), lamellar bodies (LBs), tight junction (TJ), and caveolaes (Cav.). Scale bars, 5 m. Photo Credit: Laetitia Andrique (INSERM U1029), Gaelle Recher (CNRS UMR 5298).
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and further identified as a potent vasoconstrictor (30), although the 
mechanism has been long controversial due to the presence of multi-
ple specific ET-1 receptors. ETA receptors are only expressed in SMCs 
and mediate contractions, whereas ETB receptors are present in both 
ECs and SMCs and induce a combination of SMC contraction and 
EC relaxation (31). We applied 0.1 M ET-1 extraluminally (i.e., not 
by perfusion) and investigated the response of vesseloids in Fig. 4. 
From the fluorescent signal produced by Fluo-4 AM (see below), 
we measured the diameter of the vesseloid before and 6 min after 
ET-1 application (Fig. 4A). For approximately 50% of tested ves-
seloids, we detected a contraction by 5 ± 2.2% in diameter [Fig. 4A 
(top) and movie S3; n = 12], in agreement with previously reported 
contraction of rat coronary arteries perfused with ET-1 (32). This 
contractility response was confirmed by using another widely used 
vasoconstrictor agent, angiotensin (10 M). In this case, we found 
a contraction of 5.6 ± 1.3% (Fig. 4A, bottom).
To further dissect the response to vasoconstrictor agents of SMCs 
and ECs separately, we monitored the ET-1–induced calcium response 
in Fig. 4 (B and C). To this aim, we first incubated vesseloids with 
5 M Fluo-4 AM as a Ca2+-sensitive fluorescent probe (see Materials 
and Methods). Then, an individual vesseloid was immobilized with 
separate drops of agarose on both ends in a homemade microfabri-
cated chamber (33). ET-1 was puffed locally nearby the agarose-free 
section, and the corresponding calcium-dependent fluorescence 
response was monitored over time in this section. Since the calcium 
probe is not cell specific, we developed an automated statistical cell 
sorting procedure based on principal components analysis (PCA) 
of systematically extracted measurements of single-cell fluorescent 
intensity kinetics. The whole procedure is depicted in Fig. 4B. In a trial 
and error method in which parameters such as maximal fluorescence 
intensity, “time-to-peak” respective to ET-1 application, circularity, 
and cell surface were selected by pairs as potentially correlated pa-
rameters, we found that the most discriminating parameters allowing 
to sort out cells into two subpopulations were the time to peak 
(from ET-1 application to half-time value of the rising edge of the 
first fluorescence intensity peak) and the cell surface. From this 
analysis, we observed that both HUVECs and vSMCs exhibited at 
first a primary response identified as the first and biggest intensity 
peak, followed by several Ca2+ oscillations [Fig. 4B (individual 
plots) and movie S4], suggesting synchronized calcium signaling 
between HUVECs and vSMCs (34). Moreover, cells identified as 
HUVECs were found to be significantly bigger (in average) than 
vSMCs and respond faster to ET-1 application (dot plots and sorted 
traces in Fig. 4C). These functional analyses based on the unsupervised 
sorting of the two cell populations open new ways for differential 
functional analysis because a more accurate description of the calcium 
kinetics is provided for each cell type individually and in relation 
with each other.
DISCUSSION
Because of thrombogenicity issues inherent to the use of synthetic 
grafts, tissue-engineered blood vessels (TEBVs) have long been 
considered as a necessary development for vascular repair strategies 
and are still the subject of intensive research in tissue engineering 
despite the fact that the construction of the first in vitro blood vessel 
dates back to 1986 (35). This very first TEBV was obtained by cast-
ing a mix of SMCs and collagen in an annular mold. After reinforce-
ment with a synthetic fabric and removal of the mold, the tube was 
filled with ECs that eventually formed an endothelium. Together, 
the process took more than 2 weeks. Since one critical step in the 
procedure is the extraction from the annular mold, refined strate-
gies consisted of using only biodegradable polymeric scaffolds (36) 
or no synthetic compound at all. L’Heureux et al. (37) managed to 
produce TEBVs based exclusively on biological material by cultur-
ing sheets of SMCs that were rolled before seeding ECs. Combina-
tion of the rolling technique with the bioabsorbable fibrous scaffold 
has recently led to the remarkable formation of TEBVs from adipose- 
derived stem cells (38). All these approaches allow us to generate 
large vessels in the size range of arteries (4 to 10 mm) and require a 
complex and long sequence of careful manipulations (2 to 8 weeks). 
With the advent of microfluidics, microfabrication, and 3D printing 
applied to biological matter, these approaches could be automated 
and extended to the formation of preformed or de novo vascular 
networks or to small-diameter vessels (15, 39). The counterpart of 
this procedure simplification is that most aforementioned achieve-
ments were limited to the formation of endothelial tubes lacking an 
SMC sheath. To the best of our knowledge, there are two notable 
exceptions. Kawakami and colleagues (40) reported a five-step fab-
rication of tubular constructs from ECs embedded in a gelatin-alginate 
matrix fiber and SMCs that were seeded onto the outer wall before 
dissolution of the matrix. Munn and co-workers (41) managed to 
produce vascularized tumor explants in which the vasculature 
was self-assembled from cocultures of ECs and SMCs without an 
ECM. Although the vasculature consisting of multilayered tissues 
of SMCs underneath and above the endothelial network has the 
proper histoarchitecture, it takes about 14 days to establish, and the 
SMC-to-EC ratio and the seeding sequence are two critical param-
eters that strongly affect network formation.
By contrast, in the present work, we propose a strategy and 
report a proof of concept for a simple (in one step), rapid (in 1 day) 
and robust preparation of engineered functional blood vessels com-
posed of an EC lining and an SMC sheath. To do so, we used the 
alginate hollow fiber technology to control the size of the vesseloids 
and took advantage of the conceptual possibility to orient cell 
self-assembly, as demonstrated by Gartner and co-workers (14), 
who showed that luminal and basal epithelial cells from the mam-
mary gland self-organize in the incorrect configuration when cul-
tured in agarose. However, this led to a polarization of a microtissue 
and lumen formation within 3 days upon embedding in Matrigel. 
While addition of soluble factors may a priori promote morphogenic 
processes, soluble factors released by Matrigel were discarded as 
regulators of self-organization. The ability of Matrigel (in contrast 
to agarose) to interact with cells and decrease the interfacial energy 
between cells and boundary was proposed as the driving mecha-
nism (14). Our approach offers an additional validation of the uni-
versality of this concept that allows guiding cell self-assembly by 
tuning cell-matrix interactions. Mixed HUVECs and vSMCs seeded 
on a nonadhesive surface have been shown to sort out and form 
spheroidal cocultures with an outer layer composed of ECs and an 
SMC-rich core (11, 22). On the basis of the findings reported in this 
work, we claim that the introduction of a micrometer-thick layer of 
Matrigel anchored to an initially nonadhesive alginate layer is suffi-
cient to revert the configuration toward the correct architecture. 
One may, however, argue that the present configuration, which is 
tubular instead of spherical, could also alter the self-organization 
process. To critically test that the geometry of the scaffold is not 
determinant, we performed additional experiments in which ECs 
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Fig. 4. Functional properties of vesseloids: Contractility and excitability. (A) Contraction assay. Vesseloids were exposed to 0.1 M ET-1 (top) and to 10 M angio-
tensin II, and subsequent contraction was measured. Left: Overlay of the first image before vasoconstrictor application (magenta) overlaid with the image at maximal 
contraction (green). Right: Percentage of contraction measured from the difference of the tube diameter before and after drug application. (B) Calcium imaging analysis 
subsequent to ET-1 application: Methodology. Top: Color-coded representation of a vesseloid. Cells that exhibit the earliest increase of fluorescence are depicted in red, 
whereas cells that responded the latest are colored in blue. Scale bars, 200 m. Four cells are shown as examples (#14, #15, #38, and #34), and their respective fluorescence 
intensity variation is shown. From these individual traces, parameters were automatically extracted and sorted, notably by PCA with the following para meters: “delay” 
(time measured between ET-1 application and first fluorescence intensity peak) and “circ” (circularity of the cells, which depicts the cell shape), that allow the segregation 
of the two cell populations (HUVEC-like and SMC-like) used for further comparisons. (C) Calcium imaging analysis subsequent to ET-1 application: Results. Following segre-
gation of the cell populations according to the previous description, traces were analyzed by comparing relevant parameters such as “cell surface” and time to peak, showing 
that the cell population identified as HUVECs exhibits a significantly bigger size and a faster response to ET-1 application than vSMCs. AU, arbritary units.
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and SMCs were encapsulated into spherical capsules internally coated 
with Matrigel following a previously published protocol (16). We 
also observed lumenization with EC lining and formation of an ex-
ternal SMC layer (fig. S9). The major difference with the tubular 
vesseloids was that the spherical vesseloid collapsed at day 2. We 
believe that this reduced stability is related to the restricted removal 
of cellular debris and the fact that convection is screened in these 
closed (spherical) microcompartments.
It is to emphasize that vesseloids retain many characteristics of 
functional blood vessels. ECs, in vesseloids, are connected via tight 
junction between each other to form a monolayer. They express 
VE-cadherin, VCAM-1, ICAM-1, integrins, and neuropillins and 
respond to inflammatory stimuli and vasoconstrictors. The expression 
of many of the aforementioned markers is enhanced in the vesseloids 
when compared to 2D monolayer cultures. This indicates that ves-
seloids provide a suitable 3D environment. The stability of ves-
seloids is comparable to previous engineered vessels of the order of 
1 to 2 weeks. However, we found that hypoxia contributes to considerably 
increase the stability in vitro. We hypothesize that hypoxia may 
induce autocrine growth factor loops involving molecules such as 
vascular endothelial growth factors or fibroblast growth factors. 
Autocrine EC growth factor loops have been reported in earlier 
studies (42–44). The sole limitation of the present work is the lack 
of flexibility for controlling the coverage in SMCs and, in particular, 
the ability to produce multilayered SMC walls. We anticipate that 
this limitation, which does not hamper the production of functional 
vesseloids, will be overcome for larger vessels by adaptation of our 
fabrication protocol and upon in vivo graft leading to SMC recruit-
ment from the host.
How can this directed cell self-assembly into functional vessels be 
explained at a molecular level? On the one hand, the ECM coating, 
which plays a determining role, constitutes the foundation for SMC 
anchoring. On the other hand, it is now well established that cells 
sense chemical and physical cues from the ECM, which, in turn, may 
affect cell functions, such as gene expression, contractility, or migra-
tion (45). Matrix-dependent effects include cell traction forces that 
increase with enhanced matrix stiffness. Of direct relevance here, a 
mechanical feedback between cells and the ECM through cell trac-
tion forces may lead to large-scale cellular organization (46).
Despite this bundle of reported hints on how cell-ECM interac-
tions govern tissue architecture, it remains unclear at present how 
fast cell self-organization, as observed in our case, occurs with a rapid 
polarization of ECs and SMCs. At this stage, one may only speculate 
about the reasons for this different behavior. ECM-integrin interac-
tions could be more affine for SMCs than for ECs, providing a rationale 
to explain why SMCs outcompete ECs for ECM binding and thus 
leads to SMC/EC polarization. Moreover, laminin, which is abundantly 
present in Matrigel, has been shown to play a pivotal role in SMC 
differentiation: Adhesion receptors to laminin, 11 and 71 integrins 
and -dystroglycan, are indeed only expressed in contractile SMCs (47). 
Conversely, the interaction of ECs with Matrigel may generate an un-
favorable environment for EC spreading and monolayer formation 
that could favor, by default, SMC spreading. It is known that ECs 
when cultured on the top of Matrigel undergo rapid morphological 
changes that convert EC monolayers to a cord-like network. This 
implies that de-adhesion must occur during the conversion process 
and, thus, that de-adhesion signals are conveyed by the Matrigel matrix. 
The balance between adhesion and de-adhesion to the matrix is dif-
ferent and favors adhesion of SMCs to the Matrigel layer.
Besides this cell self-assembly, we also showed that ECs form a 
leak-free barrier that is not disturbed by the SMC layer. Tight junc-
tions were evidenced and contribute to maintain the cohesivity of 
the EC layer. Furthermore, vessel contractility is preserved in ves-
seloids, presumably mostly assigned to SMCs and triggered by the 
mechanical properties of SMCs (48). SMCs have plasticity and may 
exhibit a synthetic, migratory, or contractile phenotype, and it has 
been shown that contractile SMCs initially rounded up before 
spreading and migrating. These migratory cells are highly dynamic 
and establish communication with neighboring cells. Matrigel was 
reported to favor a contractile phenotype of SMCs with a decrease 
in mitogen-activated protein (MAP) kinase signaling (49). In mature 
blood vessels, SMCs are organized in tissues that have phenotypic 
plasticity, which allow them to oscillate from a proliferative, migra-
tory, and synthetic state to a quiescent/contractile state depending 
on the environmental constraints and pathological conditions (50). 
A strict but not well-known control of SMC plasticity is required to 
prevent pathologies such as intimal hyperplasia or circulatory disorder 
such as pulmonary artery hypertension (51). In our experimental 
setting, a promigratory phenotype may be initially favored because 
cells are injected in the presence of serum and growth factors with 
cells circulating on the inner surface of the alginate tube. At a later 
stage, once a firm interaction with the matrix has been established, 
SMCs are fully converted into a contractile phenotype.
In summary, we have developed an efficient and rapid approach 
for producing artificial mature blood vessels. Vesseloids may serve 
as a suitable model to elucidate morphogenic processes of vascular 
development and signaling mechanisms for tissue/cell polarization.
However, this achievement could also be exploited for pharma-
cological testing, tissue regeneration purposes, and vascular grafting. 
The prevalent strategy for the replacement of large vessels (>4 to 6 mm) 
is the use of autologous or synthetic grafts. Specific issues to micro-
vessels such as lumen collapse, easiness of handling, and maintenance 
of mechanical properties are solved with the vesseloids we developed. 
For further use of vesseloids in an autologous human context, the 
strategy of choice is the use of differentiated induced pluripotent 
stem cells that underwent reprogramming. Such a development will 
definitely make vesseloids a system of choice for regenerative medi-
cine and vascular grafting.
MATERIALS AND METHODS
Cell culture and maintenance
HUVECs and SMCs (C-12205 and C-12511, PromoCell) were 
maintained in endothelial growth medium 2 (EGM2; C-22111, 
PromoCell) and SMC growth medium (SMCGM2; C-22062, PromoCell), 
respectively, under water-saturated 5% CO2 atmosphere at 37°C. Cells 
were grown in collagen-I–coated flasks (10190103, Thermo Fisher 
Scientific) and detached at passage 5 for vesseloid formation.
Lentiviral production and cell transduction
HUVECs were infected by pLV-EBFP2-nuc (a gift from P. Tsoulfas; 
Addgene plasmid no. 36085), while SMCs were infected by hPGK- 
NLS-Tomato virus.
Microfluidic coextrusion device and 3D tube formation
The design of a coextrusion microfluidic device dedicated for 
spherical capsules formation has been previously described (52). 
Here, we slightly modified the design. The stereolithographic file 
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(STL) file used for 3D printing is provided as data file S1. Using this 
device, we produced alginate hollow tubes filled with both ECs 
and SMCs. Briefly, cells were injected into the central zone isolated 
from the 2.5% (w/v) AL by a 300 mM IS. Cell loading of the CCS 
varied from 33% (v/v) (routine conditions) to 38% (v/v) (maximum 
loading). Cells were dispersed in Matrigel (phenol red free: 354262, 
Corning). The cell mixture was composed of 2:1 HUVEC/vSMC 
(for example, 14 million ECs/7 million SMCs). Practically, for each 
encapsulation, we started from 300 cm2 of HUVECs and 150 cm2 of 
vSMCs. Fifty- five microliters of cell pellet was resuspended directly 
with 110 or 90 l of Matrigel (for the 33 and 38% cell loadings, 
respectively). These conditions ensure that the final Matrigel con-
centration in the tubes is about 35% (v/v), which is sufficient to create 
a continuous Matrigel layer anchored to the inner alginate wall (16). 
Most experiments were performed using the following injection flow 
rates: 2 ml hour−1 (AL), 1 ml hour−1 (IS), and 1 ml hour−1 (CCS). The 
impact of flow rates variation on the homogeneity of the tubes was 
investigated in Fig. 1C. A 100 mM calcium bath at 37°C was used to 
trigger rapid gelation of the alginate gel while avoiding osmotic shock. 
Immediately after formation (within less than 10 min), the tubes were 
transferred in HUVEC and vSMC growth medium mixture (1:1 EGM2/
SMCGM2) and incubated at 37°C. This procedure developed for vessel-
oid preparation was patented (please see details in Acknowledgments).
Immunofluorescence analysis
Vesseloids were fixed in 4% paraformaldehyde (F8775, Sigma-Aldrich) 
overnight at 4°C before a 30-min permeabilization at room tem-
perature in Dulbecco’s modified Eagle’s medium (DMEM; P04-05545, 
PAN Technology) and 0.1% Triton X-100. Nonspecific sites were 
saturated by 1% bovine serum albumin and 2% fetal bovine serum 
in DMEM for 1 hour at 4°C under agitation. Vesseloids were then 
incubated at 4°C overnight under shaking, with an anti-CD31 sheep 
polyclonal antibody (1:100; AF806, R&D), anti-SMA mouse mono-
clonal antibody (1:100; MAB1420, R&D), anti-tubulin mouse mono-
clonal antibody (1:100; T5168, Sigma), anti-laminin rabbit polyclonal 
antibody (1:100; AB30320, Abcam), anti–VE-cadherin (1:100; SC6458, 
Santa Cruz Biotechnology), or anti–fibrillin-1 (1:100; AB53075, Abcam). 
After three 15-min washes with DMEM, vesseloids were reacted with 
the corresponding secondary antibody (anti-mouse, anti-sheep, anti- 
rabbit) coupled with Alexa Fluor 488, 546 or 647 (1:400; Molecular 
Probes) for 1 hour at 4°C. After rinsing three more times with DMEM, 
vesseloids were incubated for 20 min with DAPI (1 g ml−1; D9542, 
Sigma- Aldrich) before imaging.
Optical microscopy and image analysis
One-centimeter-long fixed and immunostained vesseloid portions 
were included in 1% low gelling agarose (A9414, Sigma-Aldrich) 
within the tailored wells of the UniverSlide (33) filled with DMEM.
Confocal images of vascular tubes were acquired with a Nikon Eclipse 
Ti inverted microscope equipped with a C2Si scan head acquisition 
software (NIS-Element, NIS). Image analysis was performed with 
Fiji (https://fiji.sc/).
Proliferation and apoptosis measurement
Vesseloids were immunostained by an anti-CD31 sheep polyclonal 
antibody (1:200; AF806, R&D) and either an anti-activated caspase-3 
rabbit polyclonal antibody (1:200; G748, Promega) or anti-KI67 
monoclonal antibody (1:200; M7240, Dako) before DAPI staining, 
as described above. We chose two time points, days 1 and 5, after 
tube formation. Nuclear KI67 and activated caspase-3 signals were 
quantified using Fiji (https://fiji.sc/), on the same tube length (400 m), 
and compared at days 1 and 5.
Perfusion experiments
One day after formation, 3 cm of cell-free and cell-laden tubes (HUVECs + 
vSMCs) were cannulated using a homemade perfusion device made 
of glass capillary connected to a peristaltic pump. The 500-kDa FITC- 
dextran (FD500S, Sigma-Aldrich) and 20-kDa FITC-dextran (FD20, 
Sigma-Aldrich), at 100 mg ml−1 each, were injected into the lumen 
at one opened side of the tube, at a continuous flow rate of 1 ml 
min−1. FITC-dextran was then released in the medium from the 
opposite tube end, generating a fluorescent plume. Release of the 
fluorescent probe into the medium contributed to a fluorescent 
background increasing in time. To circumvent this difficulty, the 
permeability of the tubes was assessed by analyzing the diffusion of 
the FITC-dextran through the alginate walls. Visualization was 
performed using a fluorescent microscope (Nikon SMZ 18) for 10 min.
Transmission electron microscopy
Twenty-four hours after tube formation, vesseloids were fixed in 2% 
paraformaldehyde and 2% glutaraldehyde (20879.238, VWR) over-
night at 4°C. After three washes for 5 min in 0.1 M PB (phosphate 
buffer), vesseloids were stained with 1% OsO4 in 0.1 M PB before 
dehydration and impregnation in epoxy resin. Cross sections of the 
vesseloids were imaged with a Hitachi H7650 electron microscope 
at high magnification (×25,000 and ×50,000) at the Bordeaux Imaging 
Center microscopy facility.
Calcium imaging and contractility measurement
Intracellular Ca2+ variations were monitored on day 1 of vesseloids 
loaded with 5 M (final concentration) Fluo-4 AM calcium probe 
(F23917, Thermo Fisher Scientific). Briefly, the dye solution was 
prepared as follows: 10 g of powder was dissolved in 4 l of Pluronic 
F-127 (P3000MP, Thermo Fisher Scientific), sonicated for 10 min, 
and diluted to the final concentration in standard medium. Vessel-
oids were incubated for 45 min at 37°C, then transferred to fresh 
medium, and imaged with a stereomicroscope (Nikon SMZ 18). We 
locally applied 0.1 M ET-1 (E7764, Sigma-Aldrich) or 10 M 
angiotensin II (A9525, Sigma Aldrich), and fluorescence was col-
lected with a 10× objective and directed through a 525/50 band-pass 
filter to the camera. The acquired images were first processed for 
registration with available ImageJ plugin (StackReg). We then 
analyzed the registered images with a homemade LabView-based 
(National Instruments) software. The algorithm workflow was the 
following: (i) The background was subtracted using a region outside 
of the tube in each image. (ii) The temporal variation of fluorescence 
was then extracted pixel by pixel. (iii) Pixel fluorescence variations 
along the entire acquisition were used for automated segmentation 
of the cells (watershed based segmentation). (iv) For each segmented 
cell, time to peak and morphological features were computed.
The effect of ET-1 and angiotensin on in vivo contractility is 
classically shown by measuring the change in vascular tone (32). 
Since one advantage of the vesseloid model is that it is manipulable, 
contraction could be assessed here by handling vesseloids inside an 
imaging chamber and by directly measuring the diameter of the 
vesseloid before drug application and at maximal contraction. Image 
contrast was enhanced and normalized for the whole movie to improve 
the contrast at the border of the vesseloid and to compensate for 
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photobleaching. A line with a width of 10 pixels was drawn perpen-
dicularly to the main vesseloid axis and was used to measure the 
distance between the two walls. The percentage of contraction was 
defined as the relative diameter variation between resting and con-
tracted states of the vesseloid.
RT-qPCR analysis
ECs were obtained from either direct HUVECs (2D culture on 
Matrigel coating versus 3D in vesseloids) or CD31+ cells after CD31 
magnetic bead sorting (HUVECs + SMCs on Matrigel-coated 2D 
culture versus HUVECs + SMCs in vesseloids). RNAs were extracted 
(RNeasy mini plus kit, 74134, QIAGEN) and reverse-transcribed 
(high-capacity cDNA reverse transcription kit, 4368814, Applied 
Biosystems). qPCR analysis was performed with the same amount 
of resulting cDNA using the following primers: PODXL, AACCCG-
GCCCAAGATAAGTG (forward) and GGCAGGGAGCTTAGTGT-
GAA (reverse); ITG1, GAAGGGTTGCCCTCCAGA (forward) and 
GCTTGAGCTTCTCTGCTGTT (reverse); NRP1, CAAGGCGAAG-
TCTTTTGAGG (forward) and CACCTGTGAGCTGGAAGTCA 
(reverse); NRP2 CTGTGGGTCATCCGTGAGGAC (forward) and 
ATGGGTTCCATGCAGTTCTCCAG (reverse); VCAM-1, CGTCT-
TGGTCAGCCCTTCCT (forward) and ACATTCATATACTC-
CCGCATCCTTC (reverse); ICAM-1 AGGCCACCCCAGAGGA-
CAAC (forward) and ICAM-1 CCCATTATGACTGCGGCTGCTA 
(reverse); and GAPDH, CTGCACCACCAACTGCTTAG (forward) 
and AGGTCCACCACTGACACGTT (reverse).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5 software 
(GraphPad, La Jolla, CA) using one-sample t test, Mann-Whitney U 
test, or paired t test for ET-1 contractility measurement. For all sta-
tistics, the n value used to calculate the statistics is given in the figure 
legends. ****P < 0.0001, ***P < 0.001, **P < 0.01,*P < 0.05, and bars 
represent means ± SD.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/6/eaau6562/DC1
Fig. S1. Dimension and shape of the coextrusion chip.
Fig. S2. Uniform laminin coating of the inner alginate wall.
Fig. S3. Diameter tube measurement using three coextrusion devices of different nozzle sizes.
Fig. S4. Immunostainings of CD31, fibrillin-1, and VE-cadherin were performed on vesseloids at day 1.
Fig. S5. Expression measurement of (i) basal and luminal markers, (ii) arterial and venous 
markers, and (iii) endothelial activation markers in regular culture conditions and in response 
to inflammatory stimuli.
Fig. S6. Quiescent cells at day 1 by loading the maximum of cells in the vesseloids.
Fig. S7. Hypoxia culture stabilizes the vesseloids.
Fig. S8. Vesseloid imaged by TEM at high magnification (×25,000 and ×50,000) after 1 day of 
culture.
Fig. S9. Lumenization with EC lining and formation of an external SMC layer in spherical 
capsules.
Movie S1. ECs and SMCs are dynamic after encapsulation.
Movie S2. The 20-kDa FITC-dextran perfusion.
Movie S3. ET-1 induces vesseloid contraction.
Movie S4. ET-1 induces intracellular calcium raise in both ECs and SMCs.
Data file S1. STL file of the coextrusion chip.
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